FDA Clears Anticlotting Drug by Bristol and Pfizer

FDA Clears Anticlotting Drug by Bristol and Pfizer

Filed under: drug treatment centers in pennsylvania

The drug, also known as apixaban, is the third anticlotting medicine to be approved in recent years and the companies are expected to aggressively compete to pitch their products as a replacement for warfarin, an older treatment that requires more …
Read more on New York Times